Clinical trial
Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy
NCT02166060 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy
- Lead sponsor
- Medical University of Warsaw
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- August 31, 2014
- Completion date
- October 31, 2016
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.